Literature DB >> 31699518

Dialysis Care and Dialysis Funding in Asia.

Sydney C W Tang1, Xueqing Yu2, Hung Chun Chen3, Naoki Kashihara4, Hyeong Cheon Park5, Adrian Liew6, Bak Leong Goh7, Maria Gina C Nazareth8, Sakarn Bunnag9, Jackson Tan10, Virithy Lun11, Aida Lydia12, Sanjib K Sharma13, Ehteshamul Hoque14, Ariunaa Togtokh15, Mohammad Ghnaimet16, Vivekanand Jha17.   

Abstract

Asia is the largest and most populated continent in the world, with a high burden of kidney failure. In this Policy Forum article, we explore dialysis care and dialysis funding in 17 countries in Asia, describing conditions in both developed and developing nations across the region. In 13 of the 17 countries surveyed, diabetes is the most common cause of kidney failure. Due to great variation in gross domestic product per capita across Asian countries, disparities in the provision of kidney replacement therapy (KRT) exist both within and between countries. A number of Asian nations have satisfactory access to KRT and have comprehensive KRT registries to help inform practices, but some do not, particularly among low- and low-to-middle-income countries. Given these differences, we describe the economic status, burden of kidney failure, and cost of KRT across the different modalities to both governments and patients and how changes in health policy over time affect outcomes. Emerging trends suggest that more affluent nations and those with universal health care or access to insurance have much higher prevalent dialysis and transplantation rates, while in less affluent nations, dialysis access may be limited and when available, provided less frequently than optimal. These trends are also reflected by an association between nephrologist prevalence and individual nations' incomes and a disparity in the number of nephrologists per million population and per thousand KRT patients.
Copyright © 2019 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Asia; China; Dialysis; cost of care; dialysis modality; end-stage renal disease (ESRD); geographical differences; health care financing; health care policy; hemodialysis (HD); kidney failure; nephrology workforce; peritoneal dialysis (PD); renal replacement therapy (RRT); review

Year:  2019        PMID: 31699518     DOI: 10.1053/j.ajkd.2019.08.005

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  8 in total

1.  Global Dialysis Perspective: Thailand.

Authors:  Talerngsak Kanjanabuch; Kullaya Takkavatakarn
Journal:  Kidney360       Date:  2020-04-24

2.  Emergent initiation of dialysis is related to an increase in both mortality and medical costs.

Authors:  Yuki Shimizu; Junichiro Nakata; Naotake Yanagisawa; Yuka Shirotani; Haruna Fukuzaki; Nao Nohara; Yusuke Suzuki
Journal:  Sci Rep       Date:  2020-11-12       Impact factor: 4.379

3.  Comparison of clinical features and outcomes in peritoneal dialysis-associated peritonitis patients with and without diabetes: A multicenter retrospective cohort study.

Authors:  Ling-Fei Meng; Li-Ming Yang; Xue-Yan Zhu; Xiao-Xuan Zhang; Xin-Yang Li; Jing Zhao; Shi-Chen Liu; Xiao-Hua Zhuang; Ping Luo; Wen-Peng Cui
Journal:  World J Diabetes       Date:  2020-10-15

4.  Intervention Value of Path-Type Health Education on Cognition and Renal Function of Patients with Diabetic Nephropathy.

Authors:  Lianfang Bao
Journal:  Comput Math Methods Med       Date:  2021-12-22       Impact factor: 2.238

5.  Assessing the impact of screening, early identification and intervention programmes for chronic kidney disease: protocol for a scoping review.

Authors:  Ikechi G Okpechi; Fergus J Caskey; Abduzhappar Gaipov; Elliot K Tannor; Laura N Hamonic; Gloria Ashuntantang; Jo-Ann Donner; Ana Figueiredo; Reiko Inagi; Magdalena Madero; Charu Malik; Monica Moorthy; Roberto Pecoits-Filho; Vladimir Tesar; Adeera Levin; Vivekanand Jha
Journal:  BMJ Open       Date:  2021-12-16       Impact factor: 2.692

6.  Potential Therapeutic Targets of Rehmannia Formulations on Diabetic Nephropathy: A Comparative Network Pharmacology Analysis.

Authors:  Kam Wa Chan; Kam Yan Yu; Wai Han Yiu; Rui Xue; Sarah Wing-Yan Lok; Hongyu Li; Yixin Zou; Jinyuan Ma; Kar Neng Lai; Sydney Chi-Wai Tang
Journal:  Front Pharmacol       Date:  2022-03-21       Impact factor: 5.810

Review 7.  Peritoneal dialysis: the ideal bridge from conservative therapy to kidney transplant.

Authors:  Sydney C W Tang; Kar Neng Lai
Journal:  J Nephrol       Date:  2020-07-11       Impact factor: 3.902

8.  Interaction between central obesity and frailty on the clinical outcome of peritoneal dialysis patients.

Authors:  Gordon Chun-Kau Chan; Jack Kit-Chung N G; Kai-Ming Chow; Vickie Wai-Ki Kwong; Wing-Fai Pang; Phyllis Mei-Shan Cheng; Man-Ching Law; Chi-Bon Leung; Philip Kam-Tao L I; Cheuk Chun Szeto
Journal:  PLoS One       Date:  2020-10-26       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.